Literature DB >> 18337591

Silencing of the mineralocorticoid receptor by ribonucleic acid interference in transgenic rats disrupts endocrine homeostasis.

Hee-Young Lim1, Jens van den Brandt, Martin Fassnacht, Bruno Allolio, Marco J Herold, Holger M Reichardt.   

Abstract

Currently, gene disruption by homologous recombination in embryonic stem cells is only feasible in mice. To circumvent this problem, we silenced mineralocorticoid receptor (MR) expression by RNA interference in knockdown rats generated through lentiviral transgenesis. Analysis of the F1 progeny at 3 wk of age revealed strongly decreased MR levels. This was specific for the targeted gene and related to the abundance of the short interfering RNA. Reminiscent of MR knockout mice, the transgenic rats showed a reduced body weight, elevated serum aldosterone levels, increased plasma renin activity, and altered expression of MR target genes. Some of these effects correlated with the degree to which MR mRNA expression was reduced. Whereas disruption of the MR by gene targeting in mice leads to postnatal death, our strategy also allowed obtaining adult knockdown rats with defects in hormone and electrolyte homeostasis resembling pseudohypoaldosteronism. In conclusion, this is the first example of a human disease model based on RNA interference in rats.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18337591      PMCID: PMC5419536          DOI: 10.1210/me.2007-0417

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  20 in total

1.  Lentivirally generated eGFP-transgenic rats allow efficient cell tracking in vivo.

Authors:  Jens van den Brandt; Dapeng Wang; Soon-Hwan Kwon; Martin Heinkelein; Holger M Reichardt
Journal:  Genesis       Date:  2004-06       Impact factor: 2.487

2.  Sustained pre-TCR expression in Notch1IC-transgenic rats impairs T cell maturation and selection.

Authors:  Jens van den Brandt; Soon-Hwan Kwon; Thomas Hünig; Kirsty G McPherson; Holger M Reichardt
Journal:  J Immunol       Date:  2005-06-15       Impact factor: 5.422

3.  Blood pressure reduction and diabetes insipidus in transgenic rats deficient in brain angiotensinogen.

Authors:  M Schinke; O Baltatu; M Böhm; J Peters; W Rascher; G Bricca; A Lippoldt; D Ganten; M Bader
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-30       Impact factor: 11.205

4.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.

Authors:  Douglas A Rubinson; Christopher P Dillon; Adam V Kwiatkowski; Claudia Sievers; Lili Yang; Johnny Kopinja; Dina L Rooney; Mingdi Zhang; Melanie M Ihrig; Michael T McManus; Frank B Gertler; Martin L Scott; Luk Van Parijs
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

5.  Tissue-specific and reversible RNA interference in transgenic mice.

Authors:  Ross A Dickins; Katherine McJunkin; Eva Hernando; Prem K Premsrirut; Valery Krizhanovsky; Darren J Burgess; Sang Yong Kim; Carlos Cordon-Cardo; Lars Zender; Gregory J Hannon; Scott W Lowe
Journal:  Nat Genet       Date:  2007-06-17       Impact factor: 38.330

6.  Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor.

Authors:  Caroline Ronzaud; Johannes Loffing; Markus Bleich; Norbert Gretz; Hermann-Josef Gröne; Günther Schütz; Stefan Berger
Journal:  J Am Soc Nephrol       Date:  2007-05-02       Impact factor: 10.121

7.  Pluripotent embryonic stem cells from the rat are capable of producing chimeras.

Authors:  P M Iannaccone; G U Taborn; R L Garton; M D Caplice; D R Brenin
Journal:  Dev Biol       Date:  1994-05       Impact factor: 3.582

8.  Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism.

Authors:  S Berger; M Bleich; W Schmid; T J Cole; J Peters; H Watanabe; W Kriz; R Warth; R Greger; G Schütz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

9.  In vivo RNA interference demonstrates a role for Nramp1 in modifying susceptibility to type 1 diabetes.

Authors:  Stephan Kissler; Patrick Stern; Kazue Takahashi; Kara Hunter; Laurence B Peterson; Linda S Wicker
Journal:  Nat Genet       Date:  2006-03-19       Impact factor: 38.330

Review 10.  The new biology of aldosterone.

Authors:  John M C Connell; Eleanor Davies
Journal:  J Endocrinol       Date:  2005-07       Impact factor: 4.286

View more
  5 in total

Review 1.  Aldosterone Production and Signaling Dysregulation in Obesity.

Authors:  Andrea Vecchiola; Carlos F Lagos; Cristian A Carvajal; Rene Baudrand; Carlos E Fardella
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  GPR48 increases mineralocorticoid receptor gene expression.

Authors:  Jiqiu Wang; Xiaoying Li; Yingying Ke; Yan Lu; Feng Wang; Nengguang Fan; Haiyan Sun; Huijie Zhang; Ruixin Liu; Jun Yang; Lei Ye; Mingyao Liu; Guang Ning
Journal:  J Am Soc Nephrol       Date:  2011-12-01       Impact factor: 10.121

3.  Osmotic stress regulates mineralocorticoid receptor expression in a novel aldosterone-sensitive cortical collecting duct cell line.

Authors:  Say Viengchareun; Peter Kamenicky; Marie Teixeira; Daniel Butlen; Geri Meduri; Nicolas Blanchard-Gutton; Christine Kurschat; Aurélie Lanel; Laetitia Martinerie; Shoshana Sztal-Mazer; Marcel Blot-Chabaud; Evelyne Ferrary; Nadia Cherradi; Marc Lombès
Journal:  Mol Endocrinol       Date:  2009-10-21

4.  Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats.

Authors:  Marco J Herold; Jens van den Brandt; Jost Seibler; Holger M Reichardt
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-18       Impact factor: 11.205

5.  Inducible Knock-Down of the Mineralocorticoid Receptor in Mice Disturbs Regulation of the Renin-Angiotensin-Aldosterone System and Attenuates Heart Failure Induced by Pressure Overload.

Authors:  Elena Montes-Cobos; Xiao Li; Henrike J Fischer; André Sasse; Sebastian Kügler; Michael Didié; Karl Toischer; Martin Fassnacht; Ralf Dressel; Holger M Reichardt
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.